ClinConnect ClinConnect Logo
Search / Trial NCT06435494

Cross-sectorial Use of Patient-Reported Outcomes in Chronic Degenerative Shoulder Conditions

Launched by UNIVERSITY HOSPITAL, GENTOFTE, COPENHAGEN · May 23, 2024

Trial Information

Current as of September 15, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

This study is asking whether regularly using patient-reported outcomes (PROs)—simple questionnaires about your pain, function, and overall well-being—across different health care providers helps people with chronic shoulder problems. It will compare two groups: one where PRO results are used to guide treatment (the intervention) and a control group where PRO results are collected but not used during treatment. Participants will complete PROs every 3 months for 2 years. The main thing the researchers will compare is cost per unit of improvement in life quality over the two years, using a standard health score and counting costs from hospital visits, physical therapy, and primary care.

Eligible participants are adults 18 years and older with ongoing shoulder pain from degenerative or non-acute conditions (such as bursitis, shoulder impingement, rotator cuff issues, osteoarthritis, frozen shoulder, or related problems). Key criteria include being able to understand Danish, using electronic communications, and not having factors that could bias consent or response (for example, certain medical or life situations or involvement with participating centers). The trial is taking place in Denmark at several sites, aiming to enroll about 1,000 people starting in 2024, with results anticipated after the 2-year follow-up. No results are available yet.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • shoulder pain with no acute trauma
  • Exclusion Criteria:
  • Age \<18 years
  • Non-Danish citizenship
  • Unable to understand written or spoken Danish
  • Inability to master electronic means of communication and/or not having an electronic communication (E-boks)
  • Employee at participating centre or other relation to participating health professionals that might affect independent consent
  • Psychiatric conditions, mental conditions and substance abuse that might affect the ability to provide informed consent or responding to PROMs
  • Disseminated malignant condition, other serious medical conditions or other life crisis where the focus on a shoulder research project is unreasonable
  • Already included in the study with the contralateral shoulder

About University Hospital, Gentofte, Copenhagen

University Hospital Gentofte, located in Copenhagen, is a leading academic medical center renowned for its commitment to advanced healthcare and innovative research. As a prominent sponsor of clinical trials, the hospital integrates cutting-edge medical practices with rigorous scientific inquiry, facilitating the development of new therapies and treatment protocols. With a multidisciplinary team of experts and state-of-the-art facilities, University Hospital Gentofte plays a pivotal role in enhancing patient care and contributing to the global medical community through its dedication to clinical research and education.

Locations

Gentofte, Hellerup, Denmark

Hellerup, Denmark

Hellerup, Denmark

Rødovre, Denmark

Rødovre, Denmark

Charlottenlund, Denmark

Patients applied

0 patients applied

Trial Officials

Anders Odgaard, MD, DrMed

Study Director

Rigshospitalet, Denmark

Anne M Nyholm, MD, PhD

Principal Investigator

University Hospital, Gentofte, Copenhagen

Bo S Olsen, MD, PhD

Study Chair

University Hospital, Gentofte, Copenhagen

Carsten B Juhl, PT, MPH, PhD

Study Chair

University Hospital, Gentofte, Copenhagen

Bente A Esbensen, Cand.cur., PhD

Study Chair

Rigshospitalet, Denmark

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported